APO-Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Country: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Доступно од:

Arrotex Pharmaceuticals Pty Ltd

INN (Међународно име):

pemetrexed disodium hemipentahydrate

Фармацеутски облик:

Injection, powder for

Састав:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; mannitol

Пут администрације:

Intravenous Infusion

Јединице у пакету:

1

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Резиме производа:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус ауторизације:

Registered

Датум одобрења:

2014-09-04